PINK1-dependent Mitophagy Mediates CD8+ T Cell Residency and Drives Psoriatic Relapse via CCR4-CCL17/22 Recruitment

Psoriasis is a stubborn skin condition where patches of red, scaly skin appear and then seem to disappear, only to return later in the exact same spots. For decades, doctors have known that the body's immune system is the engine driving this inflammation, but they struggled to understand why the disease keeps coming back to the same location even after the visible rash has healed. The answer lies in a specific type of immune cell called a tissue-resident memory T cell. Unlike other immune cells that patrol the body and then leave, these cells decide to stay put in the skin, forming a permanent garrison. They lie in wait, ready to restart the inflammation the moment they sense a trigger. The big question for researchers has been: what keeps these cells alive and waiting in such a harsh, inflamed environment for so long?

A team of researchers at Huashan Hospital in Shanghai has now uncovered a surprising answer. They found that these stubborn immune cells rely on a specific internal recycling process to survive, and this process is triggered by a chemical signal from neighboring cells. The study reveals that a molecule called CCR4, which sits on the surface of the immune cells, acts as a switch. When this switch is flipped by signals from nearby skin cells, it activates an internal cleanup crew known as mitophagy. This crew sweeps out damaged parts of the cell's power plants, allowing the immune cell to stay healthy and remain in the skin. Without this cleanup, the cells would likely die or leave. By blocking this specific signal, the researchers were able to stop the cells from staying behind, which prevented the skin disease from returning in mouse models.

To understand how this works, one must first look at the microscopic world inside the skin. The researchers began by examining skin samples from people with psoriasis and comparing them to healthy skin. They used advanced technology to read the genetic instructions inside thousands of individual cells at once. This allowed them to see which cells were present and what they were doing. They discovered that the immune cells causing the problem were heavily focused on a process called mitophagy. In simple terms, cells have tiny power plants called mitochondria that generate energy. Over time, these power plants get damaged. Mitophagy is the process of identifying those broken power plants and recycling them so the cell can continue to function. The researchers found that the immune cells in the psoriasis patches were constantly running this recycling process at a very high level.

The team noticed something else interesting. These same immune cells were also packed with a protein called CCR4. In the past, scientists thought CCR4 was just a navigation tool, helping immune cells find their way to the skin. However, the data suggested it was doing more than just guiding the cells there. The researchers found a strong link between the presence of CCR4 and the high level of mitophagy. It appeared that the CCR4 signal was telling the cell to start cleaning out its damaged power plants. To test this, they took immune cells from patients and treated them with a drug that blocks CCR4. When they blocked this signal, the cells stopped cleaning out their damaged power plants. The power plants began to swell and break down, and the cells lost their energy. Crucially, these cells also lost the markers that tell them to stay in the skin, suggesting they were no longer able to maintain their resident status.

The researchers then looked at the neighborhood around these immune cells to see who was sending the signal. They found that a specific type of skin cell, known as a Langerhans cell, was producing the chemical signals that activated CCR4. Using a technique that maps where molecules are located in a tissue sample, they saw that these skin cells and the immune cells were packed tightly together in specific clusters. The skin cells were essentially whispering instructions to the immune cells, telling them to stay and to keep their internal machinery running smoothly. This close physical relationship explained how the immune cells knew to remain in that specific spot and how they managed to survive the stress of the inflamed skin.

To prove that this mechanism was the key to the disease coming back, the team turned to mice. They created a model of psoriasis that mimics the human condition, where the skin becomes inflamed and then heals, only to flare up again later. They treated some of the mice with a drug that blocks the CCR4 signal. In the mice that received the drug, the skin healed and, more importantly, did not flare up again when the researchers tried to trigger a relapse. The immune cells that usually stay behind to cause the return of the disease were not there. In contrast, the mice that did not receive the drug saw their immune cells remain in the skin, and the disease returned with full force. The researchers also tested the opposite effect. When they gave a drug that forced the mitophagy process to work even harder, the immune cells stayed in the skin more aggressively, and the disease became worse.

The study also explored what happens inside the cells when this system is broken. Using powerful microscopes, the researchers looked at the tiny structures inside the immune cells. In the mice where the CCR4 signal was blocked, the power plants inside the cells looked swollen and damaged, with their internal structures falling apart. The cells also had less energy available to them. This confirmed that without the CCR4 signal, the cells could not clean out their trash, leading to a buildup of damage that made it impossible for them to survive in the skin. The researchers also checked a different type of recycling signal, one that involves a molecule called BNIP3, but they found that this pathway was not the one being used. The cells were specifically relying on the CCR4 signal to activate the PINK1 protein, which is the master switch for the mitophagy process.

This discovery changes the way scientists view the return of psoriasis. It suggests that the disease comes back not just because of a general immune response, but because a specific group of cells has found a way to stay alive in the skin by constantly recycling their own damaged parts. This survival strategy is triggered by a direct conversation between the immune cells and their neighbors. The researchers found that the amount of CCR4 on the cells in the blood of patients was actually lower than in healthy people, which implies that these cells are being pulled out of the blood and into the skin where they are activated. Once inside, they lock themselves into place by keeping their internal recycling machines running.

The implications of this finding are significant for how the disease might be treated in the future. Current treatments often focus on reducing inflammation broadly, but they do not always prevent the disease from returning to the same spot. This study suggests that targeting the specific signal that tells these cells to stay, or blocking the internal recycling process they rely on, could break the cycle of relapse. The researchers showed that by interrupting this specific pathway, they could clear the skin and prevent the disease from coming back in their mouse models. While this work was done in mice and in cells from human patients, it provides a clear new target for developing therapies that could help patients achieve long-term remission. The study does not claim to have a cure yet, but it has identified the exact mechanism that allows the disease to hide in the skin and wait for the chance to return.

The research team used a variety of tools to reach these conclusions, from analyzing genetic data from human skin samples to creating detailed maps of where cells are located in the tissue. They also used genetic techniques to create mice that lacked the PINK1 protein, which confirmed that this specific protein is essential for the cells to stay in the skin. When these mice were tested, they showed much milder symptoms and did not experience the same level of relapse as normal mice. This genetic evidence supports the idea that the mitophagy process is not just a side effect of the disease, but a fundamental requirement for the immune cells to maintain their residency.

In the end, the story of psoriasis relapse is a story about survival. The immune cells that cause the disease have learned to adapt to a difficult environment by keeping their internal machinery clean and efficient. They do this by listening to a specific signal from the skin cells around them. By understanding this conversation, scientists have found a way to silence it. The work demonstrates that the key to stopping the disease from returning may lie in disrupting the very process that allows the immune cells to survive in the first place. This approach offers a new path forward, moving beyond simply calming the inflammation to addressing the root cause of why the disease keeps coming back to the same place.